+(91) 79 4891 1722

info@ralingtonpharma.com

Edaravone

Edaravone is a nootropic andneuroprotective agent used for the purpose of aiding neurological recoveryfollowing acute brain ischemia and subsequent cerebral infarction.

Ralington pharma LLP (India), a globalmanufacturer and supplier for Edaravone, 89-25-8 for R&D, Pilot orCommercials  Quantities withPharmacopeial Grade USP/ EP/ BP/ IP/ JP/In-House.

Edaravone, 89-25-8 available with USDMF,EDMF, DMF, USFDA, EUGMP, GMP, ISOCERTIFIED,WHO-GMP and DMF as per the requirement. Product supply inStandard Packaging & labeling as per FDA along with supportivedocumentation. We can also offer Intermediates of  Edaravone, 89-25-8.

ProductType : API
Molecular Formula : C10H10N2O
CASNo : 89-25-8
Grades : GMP,USP,BP,EP,DMF
Molecular Weight : 174.20
Synonym : 3-Methyl-1-phenyl-2-pyrazolin-5-one, 2,4-Dihydro-5-methyl-2-phenyl-3H-pyrazol-3-one,1-Phenyl-3-methyl-5-pyrazolone,

Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.

Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).

Top